RebeccaKruse-JarresMD
Hematology • Seattle, WAHemophilia & Bleeding Disorder
Professor, Medicine, University of Washington, School of Medicine
Dr. Kruse-Jarres is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
921 Terry Ave
Seattle, WA 98104Phone+1 206-689-6507
Education & Training
Tulane UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005- Tulane UniversityResidency, Internal Medicine, 1999 - 2002
- Tulane University School of MedicineClass of 1999
Certifications & Licensure
AK State Medical License 2019 - 2026
MT State Medical License 2022 - 2026
ID State Medical License 2022 - 2025
WA State Medical License 2014 - 2025
LA State Medical License 2000 - 2018- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 245 citationsAcquired hemophilia A: Updated review of evidence and treatment guidance.Rebecca Kruse-Jarres, Christine L. Kempton, Francesco Baudo, Peter William Collins, Paul Knoebl
American Journal of Hematology. 2017-06-05 - 50 citationsAutoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination.Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis L. Abkowitz
Blood Advances. 2021-07-13 - 56 citationsThe effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.Johannes Oldenburg, Johnny Mahlangu, Willem Bujan, Peter Trask, Michael U. Callaghan
Haemophilia. 2019-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
